{
    "Question_1": {
        "Context": "Radiopharmaceuticals are compounds labeled with radioisotopes used in the medical field to diagnose or treat diseases. One such compound is [68Ga]Ga-FAPI-46, which targets the fibroblast activation protein and is used for imaging cancerous tissues.",
        "Question": "What is the primary use of [68Ga]Ga-FAPI-46 in medicine?",
        "A": "Imaging of cancerous tissues",
        "B": "Treatment of viral infections",
        "C": "Pain relief in chronic conditions",
        "D": "Stimulation of immune response",
        "Answer": "A",
        "Source": "Radiopharmaceuticals capable of targeting the fibroblast activation protein have become widely utilized in the research realm as well as show great promise to be commercialized; with [68Ga]Ga\u2011FAPI\u201146 being one of the most widely utilized."
    },
    "Question_2": {
        "Context": "In radiochemistry, the synthesis of radiopharmaceuticals often involves the use of a cyclotron to produce the required radioisotopes. Gallium-68 can be produced via a cyclotron using a liquid target containing enriched zinc-68.",
        "Question": "Which nuclear reaction is used in a cyclotron to produce gallium-68 for radiopharmaceuticals?",
        "A": "68Zn(d,n)68Ga",
        "B": "68Zn(p,n)68Ga",
        "C": "68Zn(n,p)68Ga",
        "D": "68Zn(n,\u03b3)68Ga",
        "Answer": "B",
        "Source": "Gallium-68 was obtained in the chemical form of [68Ga]gallium(III) nitrate ([68Ga] Ga(NO3)3) via the 68Zn(p,n)68Ga nuclear reaction, by irradiating a cyclotron liquid target containing 1 M [68Zn]Zn(NO3)2 in dilute nitric acid with a proton beam of 30\u201340 \u03bcA for 60 min."
    },
    "Question_3": {
        "Context": "The synthesis of radiopharmaceuticals requires purification steps to ensure the final product meets quality standards. One such step involves the use of chromatography resins to trap and elute specific isotopes.",
        "Question": "Which resin is used to trap gallium-68 during the purification process in the synthesis of [68Ga]Ga-FAPI-46?",
        "A": "Anion exchange resin",
        "B": "Cation exchange resin",
        "C": "ZR resin",
        "D": "TK200 resin",
        "Answer": "C",
        "Source": "The 68Ga is trapped on the first column (ZR Resin) while the zinc is not trapped on the column under these conditions."
    },
    "Question_4": {
        "Context": "In the preparation of radiopharmaceuticals, the final product must be sterile and free from bacterial endotoxins. This is often verified through specific quality control tests.",
        "Question": "What is the maximum acceptable level of bacterial endotoxins in [68Ga]Ga-FAPI-46 according to the provided quality control specifications?",
        "A": "< 1.00 EU/mL",
        "B": "< 5.00 EU/mL",
        "C": "< 8.75 EU/mL",
        "D": "< 10.00 EU/mL",
        "Answer": "C",
        "Source": "Apyrogenicity tests were performed in-house using Endosafe-Nextgen PTS (Charles River Laboratories Inc.) to ensure that doses of [68Ga]Ga-FAPI-46 contained < 8.75 endotoxin units (EU) per mL."
    },
    "Question_5": {
        "Context": "The stability of a radiopharmaceutical is crucial for its efficacy and safety. Stability studies are conducted to ensure the product maintains its purity over time.",
        "Question": "What was the observed stability duration of [68Ga]Ga-FAPI-46 at room temperature without degradation?",
        "A": "2 hours",
        "B": "4 hours",
        "C": "6 hours",
        "D": "24 hours",
        "Answer": "B",
        "Source": "Stability studies conducted at room temperature showed no degradation of the product out to 4-h, with consistent radiochemical purities by HPLC shown."
    },
    "Question_6": {
        "Context": "The radiochemical purity of a radiopharmaceutical is a measure of the proportion of the radioisotope that is in the desired chemical form. High radiochemical purity is essential for the effectiveness of the radiopharmaceutical.",
        "Question": "What is the minimum radiochemical purity percentage of [68Ga]Ga-FAPI-46 as determined by HPLC?",
        "A": "85%",
        "B": "90%",
        "C": "95%",
        "D": "99%",
        "Answer": "C",
        "Source": "The resulting [68Ga]FAPI-46 is stable out to its 4-h expiry, with no observed radioimpurity formation or increase in free gallium-68... in high radiochemical purity (> 95%) and in a fully GMP-compliant fashion."
    },
    "Question_7": {
        "Context": "In the synthesis of radiopharmaceuticals, it is important to minimize the presence of metal ion contaminants which can interfere with the radiochemical processes and the purity of the final product.",
        "Question": "What is the purpose of using metal-free conditions in the preparation of [68Ga]Ga-FAPI-46?",
        "A": "To increase the reaction speed",
        "B": "To minimize potential sources of metal ion contaminants",
        "C": "To enhance the color of the final product",
        "D": "To reduce the cost of materials",
        "Answer": "B",
        "Source": "As with many gallium radiosyntheses it is critical to minimize any potential sources of metal ion contaminants."
    },
    "Question_8": {
        "Context": "The labeling of radiopharmaceuticals involves attaching the radioisotope to a precursor molecule. This process is often carried out under controlled conditions to ensure the efficiency of labeling.",
        "Question": "At what temperature is the labeling of DOTA-FAPI-46 with gallium-68 typically performed?",
        "A": "Room temperature",
        "B": "37 \u00b0C",
        "C": "95 \u00b0C",
        "D": "100 \u00b0C",
        "Answer": "C",
        "Source": "Labelling of DOTA-FAPI-46 in an acetate buffer takes place at 95 \u00b0C over 10 min."
    },
    "Question_9": {
        "Context": "The half-life of a radioisotope is the time required for half of the radioactive atoms to decay. It is a critical parameter for identifying the radioisotope and ensuring the correct one is being used in the synthesis of a radiopharmaceutical.",
        "Question": "What is the half-life range for gallium-68 as used in the synthesis of [68Ga]Ga-FAPI-46?",
        "A": "60-63 minutes",
        "B": "64-67 minutes",
        "C": "68-71 minutes",
        "D": "72-75 minutes",
        "Answer": "B",
        "Source": "Radionuclidic identity (t1/2, minutes) 64\u201367"
    },
    "Question_10": {
        "Context": "The final formulation of a radiopharmaceutical includes passing the reaction mixture through a sterilizing filter to ensure the product is free from microbial contamination.",
        "Question": "What is the size of the sterilizing filter used in the formulation of [68Ga]Ga-FAPI-46?",
        "A": "0.1-micron",
        "B": "0.22-micron",
        "C": "0.45-micron",
        "D": "0.8-micron",
        "Answer": "B",
        "Source": "The reaction mixture is then diluted with 0.9% saline and passed through the Accell CM cartridge to the final vial through a 0.22-micron sterilizing filter."
    }
}